BlackRock Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.59M | Sell |
89,888
-51,037
| -36% | -$1.47M | ﹤0.01% | 1571 |
|
|
2016
Q3 | $4.48M | Buy |
140,925
+14,698
| +12% | +$468K | ﹤0.01% | 1157 |
|
|
2016
Q2 | $4.1M | Buy |
126,227
+41,846
| +50% | +$1.36M | ﹤0.01% | 1169 |
|
|
2016
Q1 | $2.36M | Buy |
84,381
+24,237
| +40% | +$678K | ﹤0.01% | 1430 |
|
|
2015
Q4 | $2.14M | Buy |
60,144
+4,468
| +8% | +$159K | ﹤0.01% | 1436 |
|
|
2015
Q3 | $1.84M | Buy |
55,676
+9,461
| +20% | +$313K | ﹤0.01% | 1529 |
|
|
2015
Q2 | $1.94M | Buy |
46,215
+4,500
| +11% | +$189K | ﹤0.01% | 1570 |
|
|
2015
Q1 | $1.36M | Buy |
41,715
+11,630
| +39% | +$379K | ﹤0.01% | 1680 |
|
|
2014
Q4 | $955K | Buy |
30,085
+5,281
| +21% | +$168K | ﹤0.01% | 1900 |
|
|
2014
Q3 | $615K | Sell |
24,804
-360
| -1% | -$8.93K | ﹤0.01% | 2054 |
|
|
2014
Q2 | $569K | Sell |
25,164
-18,341
| -42% | -$415K | ﹤0.01% | 2125 |
|
|
2014
Q1 | $1.06M | Buy |
43,505
+21,472
| +97% | +$522K | ﹤0.01% | 1945 |
|
|
2013
Q4 | $550K | Sell |
22,033
-249,428
| -92% | -$6.23M | ﹤0.01% | 2178 |
|
|
2013
Q3 | $7.46M | Sell |
271,461
-294,300
| -52% | -$8.08M | 0.01% | 978 |
|
|
2013
Q2 | $10.3M | Buy |
+565,761
| New | +$10.3M | 0.01% | 851 |
|